N-acetylcysteine improves EEG measures of auditory deviance detection and neural synchronization in schizophrenia: A randomized, controlled pilot study

Yvonne S. Yang; Michael C. Davis; Jonathan K. Wynn; Gerhard Hellemann; Michael F. Green; Stephen R. Marder

doi:10.1016/j.schres.2019.01.036

N-acetylcysteine improves EEG measures of auditory deviance detection and neural synchronization in schizophrenia: A randomized, controlled pilot study

Yvonne S. Yang
, Michael C. Davis
, Jonathan K. Wynn
, Gerhard Hellemann
, Michael F. Green
, Stephen R. Marder

Department of Veterans Affairs
Psychiatry Products Division
United States Food and Drug Administration
Biostatistics Core
University of California at Los Angeles

Research output: Contribution to journal › Letter › peer-review

8 Scopus citations

Original language	English
Pages (from-to)	479-480
Number of pages	2
Journal	Schizophrenia Research
Volume	208
DOIs	https://doi.org/10.1016/j.schres.2019.01.036
State	Published - Jun 2019
Externally published	Yes

Bibliographical note

Funding Information:
This work was supported by a VA MIRECC Pala Pilot Grant and a grant from the American Psychiatric Foundation to MCD. NAC and matching placebo capsules were generously donated by Vital Nutrients, Inc. Vital Nutrients, Inc., had no further role in the design, analysis, interpretation, or decision in publication of this study. For Michael C. Davis, participation occurred prior to his current position. The contents herein do not represent the views of the U.S. Department of Veterans Affairs, the U.S. Food and Drug Administration, or the United States Government.

Funding

This work was supported by a VA MIRECC Pala Pilot Grant and a grant from the American Psychiatric Foundation to MCD. NAC and matching placebo capsules were generously donated by Vital Nutrients, Inc. Vital Nutrients, Inc., had no further role in the design, analysis, interpretation, or decision in publication of this study. For Michael C. Davis, participation occurred prior to his current position. The contents herein do not represent the views of the U.S. Department of Veterans Affairs, the U.S. Food and Drug Administration, or the United States Government.

Funders
American Psychiatric Foundation

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.schres.2019.01.036

Cite this

@article{bac726bda7e54f85882d97b83c636693,

title = "N-acetylcysteine improves EEG measures of auditory deviance detection and neural synchronization in schizophrenia: A randomized, controlled pilot study",

author = "Yang, \{Yvonne S.\} and Davis, \{Michael C.\} and Wynn, \{Jonathan K.\} and Gerhard Hellemann and Green, \{Michael F.\} and Marder, \{Stephen R.\}",

note = "Funding Information: This work was supported by a VA MIRECC Pala Pilot Grant and a grant from the American Psychiatric Foundation to MCD. NAC and matching placebo capsules were generously donated by Vital Nutrients, Inc. Vital Nutrients, Inc., had no further role in the design, analysis, interpretation, or decision in publication of this study. For Michael C. Davis, participation occurred prior to his current position. The contents herein do not represent the views of the U.S. Department of Veterans Affairs, the U.S. Food and Drug Administration, or the United States Government.",

year = "2019",

month = jun,

doi = "10.1016/j.schres.2019.01.036",

language = "אנגלית",

volume = "208",

pages = "479--480",

journal = "Schizophrenia Research",

issn = "0920-9964",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - N-acetylcysteine improves EEG measures of auditory deviance detection and neural synchronization in schizophrenia

T2 - A randomized, controlled pilot study

AU - Yang, Yvonne S.

AU - Davis, Michael C.

AU - Wynn, Jonathan K.

AU - Hellemann, Gerhard

AU - Green, Michael F.

AU - Marder, Stephen R.

N1 - Funding Information: This work was supported by a VA MIRECC Pala Pilot Grant and a grant from the American Psychiatric Foundation to MCD. NAC and matching placebo capsules were generously donated by Vital Nutrients, Inc. Vital Nutrients, Inc., had no further role in the design, analysis, interpretation, or decision in publication of this study. For Michael C. Davis, participation occurred prior to his current position. The contents herein do not represent the views of the U.S. Department of Veterans Affairs, the U.S. Food and Drug Administration, or the United States Government.

PY - 2019/6

Y1 - 2019/6

UR - https://www.scopus.com/pages/publications/85066258012

U2 - 10.1016/j.schres.2019.01.036

DO - 10.1016/j.schres.2019.01.036

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 30712814

AN - SCOPUS:85066258012

SN - 0920-9964

VL - 208

SP - 479

EP - 480

JO - Schizophrenia Research

JF - Schizophrenia Research

ER -

N-acetylcysteine improves EEG measures of auditory deviance detection and neural synchronization in schizophrenia: A randomized, controlled pilot study

Bibliographical note

Funding

UN SDGs

Access to Document

Other files and links

Cite this